Research work · 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan
The Lancet
Research work · 2020
Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan
The Lancet